Expand ABEO Menu
ABEO MENU

ABEO Latest Press Releases

-- February 9, 2026 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 10:04 AM

-- December 31, 2025 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- December 15, 2025 --

Abeona Therapeutics Announces Appointment of Mohamad Tabrizi as Chief Business Officer Globe Newswire 7:30 AM

-- December 11, 2025 --

Abeona Therapeutics Announces New Qualified Treatment Center for ZEVASKYN in Texas Globe Newswire 7:30 AM

-- December 8, 2025 --

Abeona Therapeutics Announces First Patient Treatment with ZEVASKYN Gene Therapy Globe Newswire 7:30 AM

-- December 1, 2025 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- November 12, 2025 --

Abeona Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates Globe Newswire 7:30 AM

-- November 7, 2025 --

Abeona Therapeutics Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation Globe Newswire 7:30 AM

-- November 3, 2025 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- October 30, 2025 --

Abeona Therapeutics Announces Permanent J-Code for ZEVASKYN (prademagene zamikeracel) Globe Newswire 10:45 AM

-- October 20, 2025 --

Abeona Therapeutics Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs Globe Newswire 8:30 AM

-- October 13, 2025 --

Abeona Therapeutics Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program Globe Newswire 7:30 AM

-- October 8, 2025 --

Abeona Therapeutics and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN Gene Therapy Globe Newswire 7:30 AM

-- October 1, 2025 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM
Market Data Delayed 15 Minutes